Publicaciones en colaboración con investigadores/as de Medical University of Varna (1)

2018

  1. Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet Oncology, Vol. 19, Núm. 1, pp. 87-100